Literature DB >> 1290022

Transferrin microheterogeneity in rheumatoid arthritis. Relation with disease activity and anemia of chronic disease.

R A Feelders1, G Vreugdenhil, G de Jong, A J Swaak, H G van Eijk.   

Abstract

We studied the relation between disease activity in rheumatoid arthritis (RA) and the microheterogeneity of transferrin. Using crossed immuno isoelectric focusing, transferrin microheterogeneity patterns were analyzed in sera of healthy individuals, nonanemic RA patients, iron deficient RA patients and RA patients with the anemia of chronic disease (ACD). In all RA groups a significant shift in the microheterogeneity pattern was observed, reflecting increased synthesis of transferrins with highly branched glycan chains. Increased disease activity correlated with both the induction of ACD and the change in transferrin glycosylation, which was, therefore, most pronounced in ACD. Generally, an increased synthesis of glycoproteins is accompanied by alterations in their glycosylation pattern. Since transferrin is a negative acute phase protein, our results indicated that changes in synthetic rates and changes in glycosylation induced in the acute phase response are regulated independently.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1290022     DOI: 10.1007/bf00302152

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  44 in total

Review 1.  Functional properties of the carbohydrate moiety of human transferrin.

Authors:  G de Jong; H G van Eijk
Journal:  Int J Biochem       Date:  1989

2.  Changes in serum level and affinity for concanavalin A of human alpha 1-proteinase inhibitor in severe burn patients: relationship to natural killer cell activity.

Authors:  P J Lejeune; B Mallet; C Farnarier; S Kaplanski
Journal:  Biochim Biophys Acta       Date:  1989-02-24

3.  Microheterogeneity of human serum transferrin: a biological phenomenon studied by isoelectric focusing in immobilized pH gradients.

Authors:  G de Jong; H G van Eijk
Journal:  Electrophoresis       Date:  1988-09       Impact factor: 3.535

4.  Effects of monocytic products, recombinant interleukin-1, and recombinant interleukin-6 on glycosylation of alpha 1-acid glycoprotein: studies with primary human hepatocyte cultures and rats.

Authors:  O Pos; H J Moshage; S H Yap; J P Snieders; L A Aarden; J van Gool; W Boers; A M Brugman; W van Dijk
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

5.  Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease.

Authors:  S Thompson; C A Kelly; I D Griffiths; G A Turner
Journal:  Clin Chim Acta       Date:  1989-10-16       Impact factor: 3.786

6.  Anaemia of chronic disease: diagnostic significance of erythrocyte and serological parameters in iron deficient rheumatoid arthritis patients.

Authors:  G Vreugdenhil; C A Baltus; H G van Eijk; A J Swaak
Journal:  Br J Rheumatol       Date:  1990-04

7.  Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis.

Authors:  T M Hansen; N E Hansen; H S Birgens; B Hølund; I Lorenzen
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

8.  Microheterogeneity forms of alpha 1-acid glycoprotein as indicators of rheumatoid arthritis activity.

Authors:  A Mackiewicz; T Pawłowski; A Mackiewicz-Pawłowska; K Wiktorowicz; S Mackiewicz
Journal:  Clin Chim Acta       Date:  1987-03-16       Impact factor: 3.786

9.  Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.

Authors:  G Vreugdenhil; B Manger; C Nieuwenhuizen; R A Feelders; H G van Eijk; A J Swaak
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

10.  Circulating transferrin receptor in human serum.

Authors:  Y Kohgo; T Nishisato; H Kondo; N Tsushima; Y Niitsu; I Urushizaki
Journal:  Br J Haematol       Date:  1986-10       Impact factor: 6.998

View more
  7 in total

1.  Relationship between CDT and disease activity in rheumatoid arthritis.

Authors:  B Cylwik; A Chludzinska; L Chrostek; E Gruszewska; E Gindzienska-Sieskiewicz; M Szmitkowski; S Sierakowski
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 2.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

3.  Characterization of proteins in the human serum proteome.

Authors:  Edna Betgovargez; Vita Knudson; Michael H Simonian
Journal:  J Biomol Tech       Date:  2005-12

4.  5- and 6-glycosylation of transferrin in patients with Alzheimer's disease.

Authors:  Susan J van Rensburg; Peter Berman; Felix Potocnik; Pam MacGregor; Dinie Hon; Nico de Villiers
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

5.  Serum Protein N-Glycosylation Changes with Rheumatoid Arthritis Disease Activity during and after Pregnancy.

Authors:  Karli R Reiding; Gerda C M Vreeker; Albert Bondt; Marco R Bladergroen; Johanna M W Hazes; Yuri E M van der Burgt; Manfred Wuhrer; Radboud J E M Dolhain
Journal:  Front Med (Lausanne)       Date:  2018-01-08

6.  Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases.

Authors:  Lech Chrostek; Bogdan Cylwik; Ewa Gindzienska-Sieskiewicz; Ewa Gruszewska; Maciej Szmitkowski; Stanislaw Sierakowski
Journal:  Rheumatol Int       Date:  2013-12-18       Impact factor: 2.631

7.  Serum profile of transferrin isoforms in juvenile idiopathic arthritis: a preliminary study.

Authors:  Ewa Gruszewska; Magdalena Sienkiewicz; Paweł Abramowicz; Jerzy Konstantynowicz; Monika Gudowska-Sawczuk; Lech Chrostek; Bogdan Cylwik
Journal:  Rheumatol Int       Date:  2018-05-14       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.